SecBot SecBot
PRESS-RELEASE ·Filed May 15, 2026

TLX

Telix Pharmaceuticals Limited
NEUTRAL
Impact 4/10
Horizonmonths Processed6mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

This is a low-impact, non-binding exploratory collaboration announcement with no financial terms. Monitor for future definitive agreements or clinical evidence readouts that could validate expanded use of Telix's imaging agents. The insider buying is a modest positive but does not change the near-term outlook.

DirectionNeutral
Confidencemedium
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$10.56
T+0 close · May 15, 2026 · via day close
Latest settled
+13.64%
T+60 · $12.00
Vs SPY
+9.12%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 15 $10.56entry
  2. T+1 · 6mo ago −2.65%α −2.59% · $10.28
  3. T+5 · 6mo ago −10.32%α −11.29% · $9.47
  4. T+20 · 5mo ago −9.47%α −11.59% · $9.56
  5. T+60 · 3mo ago +13.64%α +9.12% · $12.00

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Telix announced non-binding letters of intent to collaborate with EDAP TMS and Profound Medical, exploring the use of its PSMA-PET imaging agents (Gozellix and Illuccix) with robotic HIFU and TULSA ablation platforms for prostate cancer. The collaborations are early-stage, focused on scientific and educational research, with no financial terms disclosed and no immediate revenue impact.

Key Facts

  • Telix entered letters of intent with EDAP TMS (Focal One robotic HIFU) and Profound Medical (TULSA-PRO MRI-guided ablation) for prostate cancer.
  • Collaborations focus on investigational use of PSMA-PET imaging agents Gozellix and Illuccix for patient selection, treatment planning, and post-treatment monitoring.
  • No financial terms, milestones, or revenue commitments were disclosed.
  • PSMA-PET imaging is not currently approved for the specific treatment-planning indications explored in these collaborations.
  • Telix's market cap is ~$3.7B; insider buying of ~$997K in the prior 30 days provides a modest positive signal.

Financial Impact

No financial terms disclosed; collaborations are non-binding and exploratory.

Risk Factors

  • Collaborations are non-binding letters of intent, may not result in definitive agreements.
  • PSMA-PET imaging is not yet approved for the specific treatment-planning indications explored.
  • No revenue or financial impact expected in the near term.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3295677

Track record

27 reports on TLX

Performance horizon

10 of 21 bullish or bearish reports moved the stock their way by T+1. Best: +29.26% at T+20 after the Jun 1, 2026 report. 19 of 21 went positive at some point.

Filters
  1. Oct 29, 202618d ago 6-K Neutral 5/10 Entry $9.10 to $9.05 Now $8.92 −1.98% ▼ −0.55% −0.07% vs SPY
  2. Oct 20, 202627d ago 6-K Neutral 4/10 No price data
  3. Oct 20, 202627d ago Press Release Bullish 6/10 Entry $10.03 to $9.54 Now $8.92 −11.07% ▼ −4.89% −3.70% vs SPY
  4. Sep 29, 20266w ago 6-K Bullish 6/10 Entry $10.97 to $10.72 Now $8.92 −18.69% ▼ −2.28% −2.46% vs SPY
  5. Sep 21, 20268w ago 6-K Bullish 7/10 Entry $11.31 to $11.95 Now $8.92 −21.13% ▲ +5.66% +5.67% vs SPY
  6. Sep 20, 20268w ago Press Release Bullish 7/10 Entry $11.31 to $11.95 Now $8.92 −21.13% ▲ +5.66% +5.67% vs SPY
  7. Sep 14, 20269w ago 6-K Bullish 8/10 Entry $12.83 to $11.83 Now $8.92 −30.48% ▼ −7.79% −7.35% vs SPY
  8. Sep 14, 20269w ago Press Release Bullish 8/10 Entry $11.78 to $12.83 Now $8.92 −24.28% ▲ +8.91% +9.37% vs SPY
  9. Sep 1, 202610w ago 6-K Bullish 7/10 Entry $11.45 to $11.74 Now $8.92 −22.10% ▲ +2.53% +1.49% vs SPY
  10. Sep 1, 202610w ago Press Release Bullish 6/10 Entry $11.45 to $11.74 Now $8.92 −22.10% ▲ +2.53% +1.49% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens Wed (10h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026